American Society of Hematology (ASH) 53rd Annual Meeting

Top News From ASH 2011: Slideshow
Highlights include using chemotherapy alone for limited-stage Hodgkin's disease, and less is more for rituximab in low-burden follicular lymphoma.

• ASH 'Twinning' Strategy Improves Cancer Care in Developing Nations
  Medscape Medical News, December 23, 2011
• ASH Powered Device Hailed as Advance for Bone Marrow Biopsy
  Medscape Medical News, December 22, 2011
• ASH RECOVER II Confirms Benefit of Dabigatran in Treatment of VTE
  Heartwire from Medscape, December 21, 2011
• ASH Education Gap Identified in the Management of MDS
  Medscape Medical News, December 19, 2011
• ASH New Model Predicts Survival in Treatment-Related MDS
  Medscape Medical News, December 16, 2011
• ASH Use of Genetically Engineered T Cells in B Cell Malignancies
  Medscape Medical News, December 15, 2011
• ASH Less Is More for Rituximab in Low-Burden Follicular Lymphoma
  Medscape Medical News, December 14, 2011
• ASH Vorinostat Shows Activity as Salvage in Multiple Myeloma
  Medscape Medical News, December 14, 2011
• ASH Postthrombotic Syndrome Risk Reduced in DVT
  Heartwire from Medscape, December 13, 2011
• ASH Less Than 10% of Retrievable IVC Filters Removed
  Heartwire from Medscape, December 13, 2011
• ASH Genetic Profile in ALL -- Should All Patients Be Screened?
  Medscape Medical News, December 13, 2011
• ASH Transplants With PBSCs Not Better Than Bone Marrow
  Medscape Medical News, December 13, 2011
• ASH Most New Myeloma Patients Respond to Carfilzomib
  Reuters Health Information, December 13, 2011
• ASH Ponatinib Helps Refractory Leukemia in Nearly Half of Patients
  Reuters Health Information, December 13, 2011
• ASH Bortezomib Upfront in Myeloma, Survival Advantage Confirmed
  Medscape Medical News, December 13, 2011
• ASH Obinutuzumab: New Drug to Replace Rituximab?
  Medscape Medical News, December 12, 2011
• ASH Massive Hunt Finds New Mutations That Drive CLL
  Medscape Medical News, December 12, 2011
• ASH Bleeding Risk Scores Provide Mixed Results
  Heartwire from Medscape, December 12, 2011
• ASH Aspirin a Safe, Low-Cost Option for Preventing Recurrent VTE
  Heartwire from Medscape, December 12, 2011
• ASH New Insight Into Drug Action in Multiple Myeloma
  Medscape Medical News, December 12, 2011
• ASH Novel Compound Holds Promise in High-Risk CLL
  Medscape Medical News, December 11, 2011
• ASH Long-Term Data Support Chemo Alone in Hodgkin's Lymphoma
  Medscape Medical News, December 11, 2011
• ASH New Lease of Life for Gemtuzumab, Now It Shows Survival Advantage
  Medscape Medical News, December 11, 2011
• ASH First Study Ever of Long-Term Problems After HCT
  Medscape Medical News, December 10, 2011
• ASH What's Hot at ASH 2011?
  Medscape Medical News, December 2, 2011